Allurion Technologies Inc
Company Profile
Business description
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world’s first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
Contact
11 Huron Drive
NatickMA01760
USAT: +1 508 647-4000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
137
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,775.00 | 4.40 | 0.05% |
| CAC 40 | 7,737.76 | 53.08 | 0.69% |
| DAX 40 | 23,589.30 | 73.07 | 0.31% |
| Dow JONES (US) | 42,197.79 | 769.83 | -1.79% |
| FTSE 100 | 8,890.76 | 40.13 | 0.45% |
| HKSE | 24,060.99 | 168.43 | 0.70% |
| NASDAQ | 19,406.83 | 255.66 | -1.30% |
| Nikkei 225 | 38,311.33 | 477.08 | 1.26% |
| NZX 50 Index | 12,690.13 | 137.26 | 1.09% |
| S&P 500 | 5,976.97 | 68.29 | -1.13% |
| S&P/ASX 200 | 8,548.40 | 1.00 | 0.01% |
| SSE Composite Index | 3,388.73 | 11.73 | 0.35% |